CHD 14
The percentage of patients with a history of myocardial infarction (from 1 April 2011) currently treated with an ACE inhibitor (or ARB if ACE intolerant), aspirin or an alternative anti-platelet therapy, beta blocker and statin (unless a contraindication or side effects are recorded)
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| CHD 11 | 2005 | 1076 | 1243 | 86.6% | |
| CHD 11 | 2006 | 1405 | 1577 | 89.1% | |
| CHD 11 | 2007 | 1682 | 1823 | 92.3% | |
| CHD 11 | 2008 | 1826 | 2000 | 91.3% | |
| CHD 11 | 2009 | 2151 | 2380 | 90.4% | |
| CHD 11 | 2010 | 2488 | 2768 | 89.9% | |
| CHD 11 | 2011 | 2748 | 3100 | 88.6% | |
| CHD 14 | 2012 | 229 | 258 | 88.8% | |
| CHD 14 | 2013 | 515 | 576 | 89.4% | |
| CHD006(S) | 2014 | 596 | 684 | 87.1% | |
| CHD006(S) | 2015 | 875 | 1001 | 87.4% | |
| CHD006(S) | 2016 | 1104 | 1254 | 88.0% |
